In December 2015 the Spanish Agency for the Protection of Health in Sport (Agencia Española de Protección de la Salud en el Deporte, AEPSAD) has reported an anti-doping rule violation against the respondent E46 after his sample tested positive for the prohibited substance propranolol.
After notification the respondent filed a statement in his defence.
He admitted the violation and stated that he had used a medication prescribed by his neurologist for his migraines and he mentioned his medication on the Doping Control Form. He acted without intention to enhance and requested for a reduced period of ineligibility and to limit the annulment of results obtained in the previous competitions.
AEPSAD accepted the respondent’s statement and decides on 10 February 2016 to impose a 9 month period of ineligibility on the respondent starting on the date of the sample collection.
